AKT1 and cancer: Significantly enriched pathways include chemokine signaling pathway, PI3K-Akt signaling pathway, transcriptional misregulation in cancer, natural killer cell-mediated cytotoxicity, and cytokine-cytokine receptor interaction (Table 5).